The discovery of LY6E as a potential objective for cancer immunotherapy has sparked considerable research . Several therapeutic candidates are being tested with the aim of specifically inhibiting LY6E's role and eliciting an antitumor effect in patients suffering with various malignancies . Challenges remain in improving protein targeting and overc